comparemela.com
  1. Home
  2. Live Updates
  3. Astrazeneca Imfinzi - Breaking News

Latest Breaking News On - Astrazeneca imfinzi - Page 1 : comparemela.com

Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer

Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United statesBoehringer ingelheim gmbAstrazeneca imfinziJay bradnerRobert langrethBloomberg amgen incHarpoon therapeutics incMerck coDrug administrationNew england journalHarpoon therapeuticsBoehringer ingelheim gmbh

Amgen Drug Wins US Approval for Type of Advanced Lung Cancer

Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working.

United statesBoehringer ingelheim gmbAstrazeneca imfinziRobert langrethJay bradnerDrug administrationMerck coHarpoon therapeutics incNew england journalHarpoon therapeuticsBoehringer ingelheim gmbh

BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial

BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Bristol myers squibbAstrazeneca imfinziJoseph fioreB cell hodgkinClinical trials arena

United States Non-small Cell Lung Cancer Digital Marketing

Dublin, April 19, 2024 (GLOBE NEWSWIRE) The

United statesUnited kingdomMerck understandcancertogetherMerck keytrudahcpAstrazeneca imfinzihcpAstrazeneca imfinziMerck keytrudaStates digital marketing trendsNon small cell lungTopics coveredResearch and marketsDigital marketingLung cancerOnline advertisingPaid searchEarch engine optimization

Rx Rundown: AbbVie, Eli Lilly, Roche and more

Check out this week’s medical marketing news, dealmaking and industry chatter.

Roche elecsysRoche genentechAstrazeneca imfinziAsher bioEli lillyHealth economics outcomes research solutionsCenters for diseaseIlant healthPractices groupDrug administrationOmnicom groupMarinus pharmaceuticalsRinger sciencesTakeda pharmaceuticalsKumquat biosciencesAdaptimmune therapeutics

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.